This is a working overview of LC-MS/MS, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-11-06. Anything still debated is marked as such rather than presented as settled.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516, GW-501516, GW 501516, endurobol | Names vary in research and anti-doping documents. |
| Chemical class | Synthetic PPARδ agonist | Small-molecule nuclear receptor ligand. |
| CAS Registry Number | 317318-70-0 | Identifier commonly associated with GW501516. |
| Appearance | White to off-white powder | Typical for purified research material. |
| Solubility | Low in water; soluble in DMSO and ethanol | Organic solvents are common for laboratory stock solutions. |
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
Air pollution in Hong Kong is considered a major problem. It became a concern soon after the start of the 2000s. According to the Environmental Protection Department (EPD), the major air pollutants in Hong Kong include nitrogen oxides (NOx), sulphur dioxide (SO2), respirable suspended particulates (RSP or PM10), fine suspended particulates (FSP or PM2.5), volatile organic compounds (VOC), carbon monoxide (CO), ozone and lead.
The most notable and recognisable series of advertisements was created by S. H. Benson's advertising, primarily drawn by the artist John Gilroy, in the 1930s and 1940s. Benson created posters that included phrases such as "Guinness for Strength", "Lovely Day for a Guinness", "Guinness Makes You Strong", "My Goodness My Guinness" (or, alternatively, "My Goodness, My Christmas, It's Guinness!"), and most famously, "Guinness Is Good for You". While modern alcohol advertising regulations prohibit such claims, vintage artefacts with the slogans remain common in Irish pubs.
Molecular studies have revealed an unexpectedly large number of cryptic lichen species. Cryptic species are genetically distinct yet morphologically similar to other species. Because many lichens differ only subtly in form or chemistry, they harbour extensive cryptic diversity. Lumbsch and Leavitt (2011) termed this a paradigm shift: morphology alone often fails to delimit species. They reviewed numerous examples across lichenology. In the large foliose lichen genus Xanthoparmelia, eight morphospecies were merged after DNA showed they formed a single lineage. Conversely, lookalike Xanthoparmelia thalli fell into several distinct lineages, increasing species counts. Genetic work on the pantropical Cladia aggregata complex uncovered at least 11 distinct species within what had been treated as one. A phylogenomic survey of the cosmopolitan granite‑dweller Lecanora polytropa pushed this pattern to the extreme, recovering up to 75 evolutionarily independent lineages within what had long been treated as a single species—about a seventy‑fold jump in recognized diversity. Such cases show that traditional concepts both lumped and split species incorrectly. Characters like growth form, colour, or the presence/absence of sexual structures (such as whether a lichen reproduces by spores or is sterile and reproduces only asexually by fragments) were often over-weighted and do not always track evolutionary lineages.
== Career == While attending the University of Hawaiʻi, Nickson was a model in Honolulu, where she appeared in her first play, The Winter's Tale. After acting classes, community theater, and roles on Magnum, P.I., she appeared as the female lead in Rambo: First Blood Part II (1985). She appeared with Chuck Norris in Sidekicks (1992). Her other film appearances have included roles in Glitch! (1988), China Cry (1991), K2 (1992), Double Dragon (1994), White Tiger (1996), Devil in the Flesh (1998), Ethan Mao (2004), Half-Life (2008), Dim Sum Funeral (2008), and One Kine Day (2011). Nickson guest starred in the final episode of seaQuest 2032 as Lieutenant Commander Heiko Kimura, a role that would have been a main character had the series continued, and in two Star Trek series: The Next Generation episode "The Arsenal of Freedom" as Enterprise-D crewmember Ensign Lian T'su, and the Deep Space Nine episode "Paradise" as Cassandra, a villager who attempts to seduce Commander Benjamin Sisko. She played Catherine Sakai, Commander Jeffrey Sinclair's love-interest, in the first season of Babylon 5. She had a recurring role as Dr. Susan Lee on the television series Walker, Texas Ranger (reuniting her with Chuck Norris), and as Princess Aouda in the 1989 miniseries version of Around the World in 80 Days opposite Pierce Brosnan and Eric Idle. She had a supporting role in the television version of the novel Noble House, again opposite Brosnan. Julia retired from acting for personal reasons on March 29, 2025
Sources: en.wikipedia.org
== Mistaken portrait == For two centuries, until the discovery of the error in 2005, books, paintings and articles had incorrectly shown a profile portrait of the obscure French politician Louis Legendre (1752–1797) as a portrait of the mathematician. The error arose from the fact that the sketch was labelled simply "Legendre" and appeared in a book along with contemporary mathematicians such as Lagrange. One of only two known portraits of Legendre, rediscovered in 2008, is found in the 1820 book Album de 73 portraits-charge aquarellés des membres de I'Institut, a book of caricatures of seventy-three members of the Institut de France in Paris by the French artist Julien-Léopold Boilly as shown below. The other portrait is from the book Le Panthéon scientifique de la tour Eiffel.
=== Youth councils === Under the terms of the Local Government Act 2002, district councils have to represent the interests of their future communities and consider the views of people affected by their decisions. To fulfill that requirement and give young people a say in the decision-making process, many councils have a youth council. In late December 2023, the Ashburton District Council scrapped their youth council, stating they could engage better with younger people online and describing the current youth council as "a youth club where they ate pizza." In early January 2024, the Gore District Council opted to restructure its youth council and ruled out dismantling it. In April 2024, the Whanganui District Council proposed scrapping its youth council by June 2024 as part of budget saving measures.
Three zoos, the Paris Zoological Park (Parc zoologique de Paris, also known as the Zoo de Vincennes), at the Bois de Vincennes in the 12th arrondissement, the Cleres Zoological Park (Parc zoologique de Clères), at a medieval manor in Clères (Seine-Maritime) and the Haute Touche Zoological Park in Obterre (Indre), the largest in France, Three botanical parks, the Arboretum de Chèvreloup in Rocquencourt next to the Château de Versailles, the Jardin botanique exotique de Menton and the Jardin alpin de La Jaÿsinia in Samoëns, Two museums, the Musée de l'abri Pataud in Les Eyzies-de-Tayac and the Harmas de Fabre in Sérignan-du-Comtat, Four scientific sites, the Institut de Paléontologie humaine in Paris, the Centre d'Écologie générale de Brunoy, the Station de Biologie marine et Marinarium de Concarneau and the CRESCO (Centre de Recherche et d'Enseignement sur les Systèmes Côtiers) in Dinard.
239Pu, a fissile isotope that is the second most used nuclear fuel in nuclear reactors after uranium-235, and the most used fuel in the fission portion of nuclear weapons, is produced from uranium-238 by neutron capture followed by two beta decays. 240Pu, 241Pu, and 242Pu are produced by further neutron capture. The odd-mass isotopes 239Pu and 241Pu have about a 3/4 chance of undergoing fission on capture of a thermal neutron and about a 1/4 chance of retaining the neutron and becoming the next heavier isotope. The even-mass isotopes are fertile but not fissile and also have a lower probability (cross section) of neutron capture; therefore, they tend to accumulate in nuclear fuel used in a thermal reactor, the design of nearly all nuclear power plants today. In plutonium that has been used a second time in thermal reactors in MOX fuel, 240Pu may even be the most common isotope. All plutonium isotopes and other actinides, however, are fissionable with fast neutrons. 240Pu does have a moderate thermal neutron absorption cross section, so that 241Pu production in a thermal reactor becomes a significant fraction as large as 239Pu production. 241Pu has a half-life of 14 years, and has slightly higher thermal neutron cross sections than 239Pu for both fission and absorption. While nuclear fuel is being used in a reactor, a 241Pu nucleus is much more likely to fission or to capture a neutron than to decay. 241Pu accounts for a significant portion of fissions in thermal reactor fuel that has been used for some time.
=== Metabolic niche partitioning === In 2010, exometabolomics analysis of the cyanobacterium, Synechococcus sp. PCC 7002 by Baran, et al. revealed that this photoautotroph could deplete a diverse pool of exogenous metabolites. A follow-up exometabolomics study on sympatric microbial isolates from biological soil crust, which exist in communities with cyanobacteria in the desert soils of the Colorado Plateau, suggested that metabolite niche partitioning exists in these communities, where each isolate only utilizes 13-26% of metabolites from the soil
Sources: en.wikipedia.org
Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.
No. Cardarine is not a steroid hormone; it targets the nuclear receptor PPARδ. Its classification in anti-doping rules differs from anabolic steroids, though it remains prohibited in sport.
Early rodent studies reported tumor formation at multiple sites, which raised safety concerns. Sponsors stopped clinical development, and no approved human product exists.
LC-MS/MS is common, often after sample cleanup. The assay targets GW501516 or its metabolites.